Analytical and preanalytical validation of a new mass spectrometric serum 5-hydroxyindoleacetic acid assay as neuroendocrine tumor marker
- 1 January 2014
- journal article
- research article
- Published by Elsevier BV in Clinica Chimica Acta; International Journal of Clinical Chemistry
- Vol. 428, 38-43
- https://doi.org/10.1016/j.cca.2013.10.025
Abstract
No abstract availableKeywords
This publication has 26 references indexed in Scilit:
- Nordic Guidelines 2010 for diagnosis and treatment of gastroenteropancreatic neuroendocrine tumoursActa Oncologica, 2010
- ENETS Consensus Guidelines for the Standards of Care in Neuroendocrine Tumors: Biochemical MarkersNeuroendocrinology, 2009
- Elevated Plasma Chromogranin A Is the First Indication of Recurrence in Radically Operated Midgut Carcinoid TumorsNeuroendocrinology, 2009
- One Hundred Years After “Carcinoid”: Epidemiology of and Prognostic Factors for Neuroendocrine Tumors in 35,825 Cases in the United StatesJournal of Clinical Oncology, 2008
- Biochemistry of neuroendocrine tumoursBest Practice & Research Clinical Endocrinology & Metabolism, 2007
- Metastatic Carcinoid Tumors: A Clinical ReviewThe Oncologist, 2005
- An analysis of 8305 cases of carcinoid tumorsCancer, 2000
- Tumor Markers in Neuroendocrine TumorsDigestion, 2000
- Simultaneous analysis of twelve biogenic amine metabolites in plasma, cerebrospinal fluid and urine by capillary column gas chromatography—high-resolution mass spectrometry with selected-ion monitoringJournal of Chromatography B: Biomedical Sciences and Applications, 1986
- THE CLASSIFICATION OF CARCINOID TUMOURSThe Lancet, 1963